$ARWR (-2,68 %) | Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs
Arrowhead Pharms
Action
Action
Ticker: ARWR
ARWR
Participez à la discussion